Treatment of skin infections


A controlled, blinded, randomised multicentre, clinical field study was carried out to assess the efficacy of Veraflox® 2.5 % oral suspension in the treatment of abscesses and/or wound infections in cats 15 ,16. Efficacy was compared to that of the authorised control product, Synulox® suspension, containing clavulanic acid potentiated amoxicillin. Inclusion criteria included bacteriological evaluation and assessment of general condition and clinical signs associated with wound infections and/or abscesses. Efficacy was evaluated based on the comparison of wound scores between treatment groups 15 ,16.

Rate this page

latest documents

3rd row with links